Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-03 Mantas Jesus B Director Grant or award +890 2,045
2020-06-03 LEAMING NANCY Director Grant or award +890 12,988
2020-06-03 HAWKINS WILLIAM A Director Grant or award +890 2,045
2020-06-03 DORSA CAROLINE Director Grant or award +890 21,097
2020-06-03 DENNER ALEXANDER J Director Grant or award +890 12,954
2020-03-11 SHERWIN STEPHEN A Director Option exercise +10,923 $58.46 $639K 16,517
2020-03-11 SHERWIN STEPHEN A Director Sale −2,164 $295.22 $639K 14,353
2020-03-11 SHERWIN STEPHEN A Director Option exercise +1,355 $58.46 $79K 15,708
2020-03-11 SHERWIN STEPHEN A Director Sale −270 $295.29 $80K 15,438
2020-03-11 SHERWIN STEPHEN A Director Option exercise · Stock Option (Right to Buy) −10,923 0
2020-03-11 SHERWIN STEPHEN A Director Option exercise · Stock Option (Right to Buy) −1,355 0
2020-02-15 Vounatsos Michel Chief Executive Officer Option exercise +4,847 33,775.32
2020-02-15 Vounatsos Michel Chief Executive Officer Shares withheld for taxes −2,150 $333.00 $716K 31,625.32
2020-02-15 Vounatsos Michel Chief Executive Officer Option exercise · Restricted Stock Unit −4,847 3,657
2020-02-15 Vounatsos Michel Chief Executive Officer Other disposition · Restricted Stock Unit −3,657 0
2020-02-15 Sandrock Alfred EVP, Research & Development Option exercise +1,213 15,019.25
2020-02-15 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −538 $333.00 $179K 14,481.25
2020-02-15 Sandrock Alfred EVP, Research & Development Option exercise · Restricted Stock Unit −1,213 915
2020-02-15 Sandrock Alfred EVP, Research & Development Other disposition · Restricted Stock Unit −915 0
2020-02-15 Galdes Alphonse EVP Pharmaceutical Oper & Tech Option exercise +441 2,672.26

Page 42 of 45 · 886 trades